Login to Your Account

Week in Washington

Monday, December 5, 2011

An FDA advisory committee is evaluating ways to make the toughest risk evaluation and mitigation strategies more effective and less burdensome.

The Senate unanimously approved an amendment to the National Defense Authorization Act that would fund Small Business Innovation and Research and Small Business Technology Transfer through fiscal 2019.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription